UNITED THERAPEUTICS Corp - Common Stock (UTHR)
CUSIP: 91307C102
Q1 2026 13F Holders as of 31 Mar 2026
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 42,833,193
- Total 13F shares
- 1,501,070
- Share change
- +73,536
- Total reported value
- $885,929,157
- Price per share
- $592.98
- Number of holders
- 200
- Value change
- +$45,062,760
- Number of buys
- 78
- Number of sells
- 94
Quarterly Holders Quick Answers
What is CUSIP 91307C102?
CUSIP 91307C102 identifies UTHR - UNITED THERAPEUTICS Corp - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
- Previous quarter: Q4 2025
Recent filing periods for CUSIP 91307C102:
Top shareholders of UTHR - UNITED THERAPEUTICS Corp - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock, Inc. |
13F
|
Company |
12%
|
5,170,766
|
$2,519,455,839 | — | 31 Dec 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
9.7%
|
4,176,016
|
$2,034,763,797 | — | 31 Dec 2025 | |
| Avoro Capital Advisors LLC |
13F
|
Company |
6.1%
|
2,606,060
|
$1,269,802,735 | — | 31 Dec 2025 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
13D/G
|
Company |
5.7%
from 13D/G
|
2,441,492
|
$1,189,616,979 | — | 31 Dec 2025 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
4.5%
|
1,909,259
|
$930,286,448 | — | 31 Dec 2025 | |
| STATE STREET CORP |
13F
13D/G
|
Company · STATE STREET CORPORATION |
4.9%
from 13D/G
|
1,842,411
|
$897,714,760 | — | 31 Dec 2025 | |
| AQR CAPITAL MANAGEMENT LLC |
13F
|
Company |
3%
|
1,281,699
|
$624,507,810 | — | 31 Dec 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
2.8%
|
1,193,064
|
$580,238,360 | — | 31 Dec 2025 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
1.9%
|
796,101
|
$387,801,106 | — | 31 Dec 2025 | |
| ASSETMARK, INC |
13F
|
Company |
1.5%
|
634,956
|
$309,382,109 | — | 31 Dec 2025 | |
| Invesco Ltd. |
13F
|
Company |
1.4%
|
608,759
|
$296,617,825 | — | 31 Dec 2025 | |
| NORGES BANK |
13F
|
Company |
1.4%
|
602,191
|
$293,417,565 | — | 31 Dec 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
1.2%
|
528,210
|
$257,405,220 | — | 31 Dec 2025 | |
| DEERFIELD MANAGEMENT COMPANY, L.P. |
13F
|
Company |
0.99%
|
425,993
|
$207,565,089 | — | 31 Dec 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.98%
|
418,427
|
$203,878,557 | — | 31 Dec 2025 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.95%
|
408,065
|
$198,830,000 | — | 31 Dec 2025 | |
| FMR LLC |
13F
|
Company |
0.94%
|
403,830
|
$196,766,016 | — | 31 Dec 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.91%
|
389,275
|
$189,675,140 | — | 31 Dec 2025 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.82%
|
352,086
|
$171,555,000 | — | 31 Dec 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.78%
|
333,629
|
$162,560,825 | — | 31 Dec 2025 | |
| Swedbank AB |
13F
|
Company |
0.76%
|
324,772
|
$158,245,158 | — | 31 Dec 2025 | |
| BAILLIE GIFFORD & CO |
13F
|
Company |
0.75%
|
323,016
|
$157,389,546 | — | 31 Dec 2025 | |
| Pictet Asset Management Holding SA |
13F
|
Company |
0.72%
|
306,837
|
$149,668,916 | — | 31 Dec 2025 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.72%
|
306,971
|
$149,571,620 | — | 31 Dec 2025 | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC |
13F
|
Individual |
0.69%
|
296,320
|
$144,381,920 | — | 31 Dec 2025 | |
| FULLER & THALER ASSET MANAGEMENT, INC. |
13F
|
Company |
0.68%
|
290,613
|
$141,600,967 | — | 31 Dec 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.68%
|
289,926
|
$141,266,444 | — | 31 Dec 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.61%
|
262,215
|
$127,764,260 | — | 31 Dec 2025 | |
| LORD, ABBETT & CO. LLC |
13F
|
Company |
0.6%
|
258,049
|
$125,734,000 | — | 31 Dec 2025 | |
| Eversept Partners, LP |
13F
|
Company |
0.59%
|
252,592
|
$123,075,452 | — | 31 Dec 2025 | |
| Nuveen, LLC |
13F
|
Company |
0.59%
|
251,809
|
$122,693,936 | — | 31 Dec 2025 | |
| Pacer Advisors, Inc. |
13F
|
Company |
0.56%
|
241,872
|
$117,852,132 | — | 31 Dec 2025 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.53%
|
228,383
|
$111,279,617 | — | 31 Dec 2025 | |
| UBS Group AG |
13F
|
Company |
0.53%
|
225,849
|
$110,044,926 | — | 31 Dec 2025 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.51%
|
219,023
|
$106,718,999 | — | 31 Dec 2025 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.51%
|
216,820
|
$105,645,545 | — | 31 Dec 2025 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.48%
|
206,543
|
$100,638,077 | — | 31 Dec 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.48%
|
205,131
|
$99,950,080 | — | 31 Dec 2025 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.47%
|
203,351
|
$99,082,775 | — | 31 Dec 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.47%
|
200,531
|
$97,668,000 | — | 31 Dec 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.44%
|
187,164
|
$91,195,659 | — | 31 Dec 2025 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.43%
|
186,164
|
$90,708,409 | — | 31 Dec 2025 | |
| CITIGROUP INC |
13F
|
Company |
0.43%
|
184,408
|
$89,852,798 | — | 31 Dec 2025 | |
| FRONTIER CAPITAL MANAGEMENT CO LLC |
13F
|
Company |
0.42%
|
181,177
|
$88,278,545 | — | 31 Dec 2025 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.42%
|
181,120
|
$88,250,721 | — | 31 Dec 2025 | |
| Legal & General Group Plc |
13F
|
Company |
0.41%
|
173,592
|
$84,582,710 | — | 31 Dec 2025 | |
| Amundi |
13F
|
Individual |
0.38%
|
163,194
|
$79,516,277 | — | 31 Dec 2025 | |
| COMERICA BANK |
13F
|
Company |
0.38%
|
161,683
|
$78,779,609 | — | 31 Dec 2025 | |
| Sofinnova Investments, Inc. |
13F
|
Company |
0.37%
|
157,641
|
$76,810,577 | — | 31 Dec 2025 | |
| SEIZERT CAPITAL PARTNERS, LLC |
13F
|
Company |
0.34%
|
145,522
|
$70,905,594 | — | 31 Dec 2025 |
Institutional Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q1 2026
As of 31 Mar 2026,
UNITED THERAPEUTICS Corp - Common Stock (UTHR) was held by
200 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,501,070 shares.
The largest 10 holders included
Swedbank AB, Pictet Asset Management Holding SA, Robeco Institutional Asset Management B.V., Retirement Systems of Alabama, Polaris Capital Management, LLC, ATWOOD & PALMER INC, WEDGE CAPITAL MANAGEMENT L L P/NC, NEW YORK STATE TEACHERS RETIREMENT SYSTEM, Assenagon Asset Management S.A., and Nepsis Inc..
This page lists
214
institutional shareholders reporting positions in this security
for the Q1 2026 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2026 vs Q4 2025 Across Filers
Q4 2025 holders
825
Q1 2026 holders
200
Holder diff
-625
| Investor | Q4 2025 Shares | Q1 2026 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q1 2026 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.